The Somatization of Emotional Conflict Scale (SECS)<\/strong>, developed by Jeffrey J. Borckardt, Jarred W. Younger, B. J. Adams, and Michael R. Nash (2000; Borckardt, 2002), is a comprehensive multidimensional psychometric instrument designed to quantify the somatic manifestation of psychological distress and emotional conflict. Unlike traditional somatic symptom inventories that merely measure the presence or frequency of physical complaints\u2014often confounding idiopathic or medically unexplained symptoms with documented physical pathology\u2014the SECS uniquely evaluates three operational parameters for 42 distinct bodily symptoms: symptom frequency (Column A), perceived functional impact or life disruption (Column B), and explicit perceived attribution to distinct affective states (Column C: anxiety\/stress, depression\/sadness, and anger\/agitation). In addition to the 42 core symptom items, the instrument includes an initial screening battery assessing medical diagnoses (e.g., irritable bowel syndrome, fibromyalgia, chronic fatigue syndrome, hypertension), current pharmacotherapy, general vulnerability to infectious illness, and demographic indicators. Psychometric evaluations across clinical, college, and community samples indicate robust internal consistency (Cronbach\u2019s α typically ranging from .89 to .96 across total and subscale scores), strong convergent validity with established measures of bodily distress, somatosensory amplification, and psychological distress (such as the SCL-90-R Somatization subscale and the Beck Depression Inventory), and sound construct validity demonstrated through exploratory and confirmatory factor analyses. The SECS offers clinicians and researchers in psychosomatic medicine<\/a>, behavioral medicine, health psychology, and clinical neuropsychology a granular, ecologically sensitive methodology to disentangle functional somatic syndromes, conversion phenomenology, and emotional distress amplification from purely organic pathophysiology.<\/p>\n Somatization of Emotional Conflict Scale, SECS, somatization, functional somatic syndromes, somatosensory amplification, psychosomatic medicine, conversion disorder, affective dysregulation, bodily distress, hypochondriasis, psychometrics, mind-body interaction, autonomic arousal, emotional conflict.<\/p>\n The Somatization of Emotional Conflict Scale was conceived and standardized by a team of clinical and experimental psychologists at the University of Tennessee, Knoxville:<\/p>\n The primary clinical and research objective of the Somatization of Emotional Conflict Scale (SECS) is to provide an empirical, clinically nuanced evaluation of the degree to which an individual translates psychological friction, unexpressed emotional tension, and affective distress into subjective bodily symptomatology. Historically, the assessment of somatization<\/a> within psychiatric nosology has been burdened by conceptual ambiguities. Standard instruments\u2014such as the Somatization Index of the Symptom Checklist-90-Revised (SCL-90-R) or the Patient Health Questionnaire-15 (PHQ-15)\u2014tabulate physical sensations without investigating the respondent\u2019s subjective awareness of the emotional triggers driving those sensations. Consequently, patients with documented systemic medical diseases (e.g., systemic lupus erythematosus, multiple sclerosis, or rheumatoid arthritis) frequently obtain pathologically elevated scores on standard somatization inventories despite experiencing symptoms rooted entirely in organic tissue damage rather than psychological etiology.<\/p>\n The SECS resolves this psychometric confound by introducing a tripartite reporting matrix for each of 42 physical symptoms. Rather than assuming that a physical symptom is psychogenic solely because a diagnostic scan failed to reveal gross structural abnormalities, the SECS asks individuals to self-report:<\/p>\n In behavioral medicine and psychosomatic specialty clinics, the SECS serves as an invaluable diagnostic and treatment-planning instrument. It helps clinicians systematically differentiate between primary organic pathologies, functional neurological disorders<\/a> (conversion disorders), central sensitivity syndromes (such as irritable bowel syndrome and fibromyalgia), and alexithymia<\/a>-mediated somatosensory amplification. In research contexts, the SECS provides an operational bridge between psychophysiological reactivity\u2014such as autonomic nervous system hyper-responsiveness, elevated sympathetic tone, or hypnotizability\u2014and subjective somatic reporting, elucidating how emotional conflict converts into visceral and musculoskeletal distress.<\/p>\n The psychological construct captured by the SECS is emotional conflict somatization<\/em>\u2014the tendency to experience, amplify, and express psychological distress, interpersonal conflict, or intrapsychic tension in the idiom of somatic illness. This overarching construct is subdivided into multiple interrelated empirical and behavioral dimensions:<\/p>\n This dimension encompasses the range and temporal density of bodily sensations across multiple physiological organ systems. Somatization is rarely restricted to an isolated physiological channel; instead, individuals prone to somatization typically exhibit multisystemic involvement. The SECS evaluates symptoms spanning:<\/p>\n The impact dimension assesses functional morbidity\u2014the extent to which bodily complaints impede daily executive functioning, social participation, occupational performance, and overall quality of life. Research in health psychology demonstrates that symptom frequency and functional disability do not correlate linearly; high somatizers frequently experience catastrophic impairment even from low-frequency, mild sensations due to attentional hypervigilance, catastrophic cognitions, and illness-related behavior.<\/p>\n This is the core conceptual innovation of the SECS. The construct does not treat somatization as a non-conscious blind spot alone, but measures the conscious or semi-conscious cognitive-emotional appraisal connecting bodily sensations with three distinct affective states:<\/p>\n The SECS is grounded in the convergence of classical psychoanalytic theory, contemporary cognitive-behavioral paradigms of somatosensory amplification, and neurobiological models of autonomic dysregulation.<\/p>\n The conceptual foundation of somatization originates in the seminal observations of Sigmund Freud and Josef Breuer regarding conversion hysteria<\/a>. In classic psychodynamic formulations, when an unacceptable emotional impulse, traumatic memory, or psychological conflict enters conscious awareness, it generates intense psychic anxiety. Through defense mechanisms\u2014specifically repression and conversion\u2014the psychological conflict is converted into an innocent physical dysfunction (the “primary gain” of symptom formation). This protects the individual from directly confronting the terrifying affect. Building upon these classical ideas, Franz Alexander and the Chicago Psychoanalytic Institute developed the field of psychosomatic medicine, identifying specific vegetative neuroses driven by unexpressed hostility, chronic dependency needs, or unresolved separation anxiety acting on autonomic neural circuits.<\/p>\n Modern cognitive formulations, particularly Arthur Barsky\u2019s model of somatosensory amplification<\/em> (Barsky & Wyshak, 1990), posit that somatization results from a three-part cognitive-perceptual process:<\/p>\n At the neurobiological level, the SECS aligns with Julian Thayer\u2019s Neurovisceral Integration Model<\/em> and Stephen Porges\u2019 Polyvagal Theory<\/em>. The central autonomic network (CAN)\u2014incorporating the anterior cingulate cortex, insular cortex, amygdala, and prefrontal regions\u2014dynamically orchestrates emotional regulation and autonomic, endocrine, and immune output. When emotional regulation fails or emotional conflict cannot be integrated cortically, parasympathetic vagal tone drops, leading to uninhibited sympathetic hyperarousal or maladaptive dorsal-vagal shutdown. This physiological dysregulation produces real, measurable somatic distress: vascular spasms, smooth muscle hypermotility, visceral hypersensitivity, and cytokine-mediated systemic inflammation. The SECS captures this interface by determining which specific emotional pathways evoke these downstream somatic expressions.<\/p>\n The psychometric validity of the SECS has been examined across several investigations evaluating its construct, convergent, discriminant, and predictive properties (Borckardt et al., 2000; Borckardt, 2002; Willis, 2002).<\/p>\n Convergent validity has been established by correlating SECS subscales and composite indices with gold-standard measures of somatic awareness, psychological distress, and neuroticism:<\/p>\n Discriminant validity is demonstrated by the SECS\u2019s capacity to differentiate between genuine organic medical conditions and affective-somatization syndromes:<\/p>\n Borckardt (2002) examined physiological reactivity during standardized affective mental imagery paradigms. Participants exhibiting high SECS scores displayed marked autonomic labilization (aberrant skin conductance fluctuations, dysregulated heart rate variability, and sustained blood pressure elevations) when guided through scripts depicting emotional conflict, confirming that high SECS scores reliably predict heightened physiological vulnerability to emotional stressors.<\/p>\n The SECS demonstrates exemplary psychometric reliability across diverse non-clinical student cohorts, outpatient psychological clinics, and community adult samples.<\/p>\n Internal consistency estimates, calculated using Cronbach\u2019s coefficient alpha (α), confirm high item homogeneity within each evaluation axis:<\/p>\n Stability across time has been evaluated in longitudinal test-retest designs over 2-week and 4-week intervals in stable university populations. The Pearson product-moment correlation coefficients were:<\/p>\n These values demonstrate that the scale measures a stable psychological trait\u2014the chronic disposition to channel psychological conflict through somatic systems\u2014while remaining sensitive to state-dependent shifts in acute life stress.<\/p>\n Both exploratory factor analysis (EFA) and confirmatory factor analysis (CFA) have been employed to clarify the structural dimensions of the SECS.<\/p>\n Principal axis factoring with oblique rotation (promax\/direct oblimin) on the 42 items within the frequency and emotional attribution matrices has consistently identified a multi-tiered, hierarchical factor architecture:<\/p>\n In structural modeling studies comparing competing models of somatization, a hierarchical bi-factor model yields superior goodness-of-fit indices compared to unidimensional or strictly orthogonal models:<\/p>\n This structural model confirms that while individuals exhibit system-specific symptom clusters (e.g., predominantly gastrointestinal or predominantly musculoskeletal), these sub-factors load onto a robust second-order general factor: General Somatization of Emotional Conflict<\/em>.<\/p>\n The SECS is administered as a self-report paper-and-pencil or computer-assisted questionnaire. It is structured into two main components: a pre-assessment medical history questionnaire and the primary 42-item somatic evaluation matrix.<\/p>\n The Somatization of Emotional Conflict Scale was formally presented in 2000<\/strong> at the annual scientific meeting of the Society for Clinical and Experimental Hypnosis in Seattle, Washington (Borckardt et al., 2000), and further elaborated in Borckardt’s 2002 doctoral dissertation at the University of Tennessee, Knoxville. Additional normative and empirical data were archived by Leah Willis (2002).<\/p>\n The SECS is an open-access psychometric instrument developed for academic, scientific, and non-commercial clinical use. The scale is archived in the University of Tennessee’s institutional academic repository (Trace: Tennessee Research and Creative Exchange, Trace ID: Demographic Profile:<\/strong><\/p>\n Sex: [ ] Male [ ] Female Age: ______ Height: ______ Weight: ______ Race: ____________<\/p>\n Do you smoke cigarettes? [ ] Yes [ ] No Common Illness Vulnerability:<\/strong>2. Keywords<\/h2>\n
3. Authors<\/h2>\n
\n
4. Purpose<\/h2>\n
\n
5. Psychological Construct<\/h2>\n
1. Somatosensory Symptom Repertoire & Frequency<\/h3>\n
\n
2. Subjective Impairment and Symptom Impact<\/h3>\n
3. Affective Contingency and Emotional Attribution<\/h3>\n
\n
6. Theoretical Framework<\/h2>\n
Psychoanalytic and Psychodynamic Roots<\/h3>\n
Cognitive-Behavioral and Somatosensory Amplification Models<\/h3>\n
\n
The Biopsychosocial and Neurovisceral Integration Perspectives<\/h3>\n
7. Validity<\/h2>\n
Convergent Validity<\/h3>\n
\n
Discriminant Validity<\/h3>\n
\n
Predictive and Experimental Validity<\/h3>\n
8. Reliability<\/h2>\n
Internal Consistency<\/h3>\n
\n
Test-Retest Reliability<\/h3>\n
\n
9. Factor Analysis<\/h2>\n
Exploratory Factor Analysis (EFA)<\/h3>\n
\n
Confirmatory Factor Analysis (CFA)<\/h3>\n
\n
10. Instrument \/ Measurement Tool<\/h2>\n
Structural Architecture<\/h3>\n
\n
\n
Rating Scales and Column Definitions<\/h3>\n
\n
\n
0<\/code> = I have never had this problem<\/li>\n1<\/code> = Less than once a month<\/li>\n2<\/code> = Once or twice a month<\/li>\n3<\/code> = Three or four times a month<\/li>\n4<\/code> = More than four times a month<\/li>\n<\/ul>\n<\/li>\n\n
0<\/code> = Never a problem at all<\/li>\n1<\/code> = Barely noticeable; not a problem<\/li>\n2<\/code> = A minor problem; small discomfort<\/li>\n3<\/code> = A problem; but can be dealt with<\/li>\n4<\/code> = Huge negative impact on my life<\/li>\n<\/ul>\n<\/li>\n\n
Scoring Guidelines and Computed Indices<\/h3>\n
\n
\n
11. Permissions & Fee and Test Year<\/h2>\n
utk_interstp2\/108<\/code>). Researchers, medical educators, and clinicians are permitted to reproduce and administer the scale without licensing fees, provided that appropriate scholarly attribution is accorded to Jeffrey J. Borckardt, Michael R. Nash, and their co-investigators in all ensuing presentations and published works. Clinical organizations, commercial software developers, and corporate entities intending to integrate the SECS into commercial diagnostic batteries or fee-for-service digital health platforms should contact the principal author directly regarding institutional terms.<\/p>\n12. References<\/h2>\n
\n
13. Items of the Scale<\/h2>\n
Part I: Background Information and Medical History<\/h3>\n
\n If yes, how many cigarettes per day? ______<\/p>\n
\n How often do you get sick with the cold, flu, or similar common illness? (Circle the most accurate response):<\/p>\n\n